Provided by Tiger Trade Technology Pte. Ltd.

PepGen Inc.

6.20
-0.2050-3.20%
Volume:117.46K
Turnover:743.89K
Market Cap:425.90M
PE:-2.19
High:6.54
Open:6.44
Low:6.15
Close:6.40
52wk High:7.80
52wk Low:0.8801
Shares:68.75M
Float Shares:45.78M
Volume Ratio:0.55
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8262
EPS(LYR):-2.8490
ROE:-62.25%
ROA:-34.09%
PB:2.61
PE(LYR):-2.17

Loading ...

PepGen Inc : Oppenheimer Initiates Coverage With Outperform Rating; Target Price $15

THOMSON REUTERS
·
Feb 25

PepGen Inc. (PEPG) Receives a New Rating from Oppenheimer

TIPRANKS
·
Feb 25

Analysts Offer Insights on Healthcare Companies: Gossamer Bio (GOSS) and PepGen Inc. (PEPG)

TIPRANKS
·
Feb 25

PepGen Inc expected to post a loss of 35 cents a share - Earnings Preview

Reuters
·
Feb 20

PepGen Is Maintained at Buy by Guggenheim

Dow Jones
·
Feb 18

PepGen price target raised to $7 from $6 at Guggenheim

TIPRANKS
·
Feb 18

Desert Control AS Appoints David Borah as Chief Financial Officer

Reuters
·
Feb 03

PepGen Inc. Files Initial Statement of Beneficial Ownership for Chief Business & Legal Officer Joseph Vittiglio

Reuters
·
Dec 11, 2025

PepGen Grants Stock Options to New Chief Business and Legal Officer

Reuters
·
Dec 09, 2025

PepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) to Newly Appointed Chief Business and Legal Officer

THOMSON REUTERS
·
Dec 09, 2025

BRIEF-PepGen Appoints Joseph Vittiglio, Esq., As Chief Business And Legal Officer

Reuters
·
Dec 08, 2025

PepGen Names Joseph Vittiglio Chief Business and Legal Officer

Reuters
·
Dec 08, 2025

PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer

THOMSON REUTERS
·
Dec 08, 2025

PepGen Inc. (PEPG) Gets a Sell from Bank of America Securities

TIPRANKS
·
Nov 16, 2025

Wedbush Raises Price Target on PepGen to $9 From $8, Keeps Outperform Rating

MT Newswires Live
·
Nov 13, 2025

PepGen price target raised to $20 from $18 at H.C. Wainwright

TIPRANKS
·
Nov 13, 2025

PepGen Inc. Strengthens Financial Position Amid Ongoing Losses

TIPRANKS
·
Nov 13, 2025

PepGen Receives US Patent for Investigational Candidate for Severe Neuromuscular Disease Treatment

MT Newswires Live
·
Nov 12, 2025

PepGen announces issuance of patent for PGN-EDODM1

TIPRANKS
·
Nov 12, 2025

PepGen Inc - Patent Provides Exclusivity for Pgn-Edodm1 in U.S. Until 2042

THOMSON REUTERS
·
Nov 12, 2025